CSIMarket
 
Gilead Sciences Inc   (GILD)
Other Ticker:  
 
 

Gilead Sciences Inc Growth Comparisons

Select each growth Category to receive further Information



GILD Revenue Growth Rate Comparisons Company Industry Sector S&P 500
Y / Y Revenue Growth (Q1 MRQ) 5.26 % -0.98 % 2.16 % 1.22 %
Q / Q Revenue Growth (Q1 MRQ) -6.02 % -19.07 % 17.86 % 1.48 %
Y / Y Revenue Growth (for 12 months ending Q1 TTM) 1.51 % -7.73 % -4.65 % %
Seq. Revenue Growth (for 12 months ending Q1 TTM) 1.23 % -0.41 % 0.26 % 0.76 %
Revenue 5 Year Average Growth 4.15 % 7.41 % 8.3 % 8 %


GILD's Growth Comparisons in I. Quarter 2024




Gilead Sciences Inc managed to grow Revenue by 5.26% year on year, in the first quarter 2024 to 6.69 billions, while Biotechnology & Pharmaceuticals industry fell by -0.98%, Healthcare sector grew 2.16%. Although Biotechnology & Pharmaceuticals industry's Sales were softer then 1.22% overall market growth, Gilead Sciences Inc and the Healthcare sector have delivered above average market Sales.

Top-line fell by -6.02% from the forth quarter. Average annual sales growth for Gilead Sciences Inc is 4.15%, while S & P 500's average yearly sales increase is 8%, including only Businesses with the first quarter 2024 financial results.


Growth Rates of GILD's Income in the first quarter 2024


GILD Operating Income Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Operating Income Change (Q1 MRQ) - - -51.07 % -2.97 %
Seq. Operating Income Change (Q1 MRQ) - - -2.13 % -4.8 %
Y / Y Operating Income Growth (Q1 TTM) -82.15 % -94.58 % -59.42 % -2.95 %
Seq. Operating Income Growth (Q1 TTM) -79.25 % -85.95 % -26.29 % 2.45 %
Operating Income 5 Year Avg. Change -1.5 % -20.81 % -0.45 % 9.4 %


Income from Cont. Ops. Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Income from Cont. Ops. Change (Q1 MRQ) - - -71.41 % 5.26 %
Seq. Income from Cont. Ops. Change (Q1 MRQ) - - -73.76 % -13.88 %
Y / Y Income from Cont. Ops. Change (Q1 TTM) -91.73 % - -69.24 % -3.58 %
Seq. Income from Cont. Ops. Change (Q1 TTM) -91.84 % - -36.49 % -0.16 %
Income from Cont. Ops. 5 Year Avg. Change 0.55 % -27.16 % -5.43 % 6.94 %

GILD Net Income Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Net Income Growth (Q1 MRQ) - - -71.58 % 0.77 %
Q / Q Net Income Growth (Q1 MRQ) - - -74.02 % -20.85 %
Y / Y Net Income Change (Q1 TTM) -91.73 % - -42.92 % -2.32 %
Seq. Net Income Change (Q1 TTM) -91.84 % - -23.45 % -0.19 %
Net Income 5 Year Avg. Growth 0.55 % -27.16 % 0 % 7.14 %

GILD's EPS Growth Rates


EPS from Cont. Ops. Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y EPS from Cont. Ops. Change (Q1 MRQ) - - -71.41 % 5.26 %
Seq. EPS from Cont. Ops. Change (Q1 MRQ) - - -73.76 % -13.88 %
Y / Y EPS from Cont. Ops. Change (Q1 TTM) -91.25 % - - -
Seq. EPS from Cont. Ops. Change (Q1 TTM) -91.41 % - - 45.89 %
EPS from Cont. Ops. 5 Year Avg. Growth 1.57 % -32.48 % -5.43 % 6.94 %



GILD EPS Net Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y EPS Net Growth (Q1 MRQ) - - -71.58 % 6.94 %
Q / Q EPS Net Growth (Q1 MRQ) - - -74.02 % -20.85 %
Y / Y EPS Net Change (for 12 months ending Q1 TTM) - - - 87481.07 %
Seq. EPS Net Change (for 12 months ending Q1 TTM) -91.96 % - - 46.15 %
EPS Net 5 Year Avg. Change 1.53 % -27.16 % 0 % 7.14 %



Gilead Sciences Inc reported bottom-line of $ -3.34 in the first quarter, compare to $ 0.80 in the same quarter a year ago. Biotechnology & Pharmaceuticals industry fell by -0.98%, while Healthcare sector decreased by -71.58%, and overall market improved by 0.77%.

the bottom-line fell by -6.02% from the forth quarter. Average annual income per share growth for Gilead Sciences Inc is 1.53%, while S & P 500's average yearly income per share increase is 7.14%, including only Businesses with the first quarter 2024 earnings.

GILD Cash Flow Growth Rates


Free Cash Flow Growth Rates Company Industry Sector S&P 500
Y / Y Free Cash Flow Change (Q1 MRQ) 27.24 % 120.22 % 6.09 % -9.09 %
Seq. Free Cash Flow Change (Q1 MRQ) 2.31 % -33.77 % -42.46 % -2.09 %
Y / Y Free Cash Flow Change (Q1 TTM) -5.51 % -34.97 % -6.74 % -4.3 %
Seq. Free Cash Flow Change (Q1 TTM) 5.93 % 5.83 % -0.85 % -4.04 %
Free Cash Flow 5 Year Avg. Change -0.15 % -13.59 % 8.92 % 12.29 %

Net Cash Flow Growth Rates Company Industry Sector S&P 500
Y / Y Net Cash Flow Change (Q1 MRQ) - - -79.24 % -
Seq. Net Cash Flow Change (Q1 MRQ) - - - -
Y / Y Net Cash Flow Change (Q1 TTM) - - - -
Seq. Net Cash Flow Change (Q1 TTM) - - - -
Net Cash Flow 5 Year Avg. Change -42.11 % 3.51 % 10.56 % -33.77 %

Capital Expenditures Company Industry Sector S&P 500
Y / Y Capital Expenditures Change (Q1 MRQ) -3.67 % -6.95 % -5.05 % -15.94 %
Seq. Capital Expenditures Change (Q1 MRQ) -51.16 % -11.4 % -22.67 % 0.06 %
Y / Y Capital Expenditures Change (Q1 TTM) -1.53 % 14.42 % 0.72 % 18.96 %
Seq. Capital Expenditures Change (Q1 TTM) -0.68 % -2.25 % -2.48 % -0.55 %
Capital Expenditures 5 Year Avg. Change -8.74 % -3.17 % 9.37 % 10.07 %

Note
To view Detail Information & Trends click on Individual Category.
To see Industry, Sector or S&P 500 Performance, click on each Category respectivly, on the top of the Table.

For explanation of terms visit: Glossary
 







Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com